Summary:
The BusinessMakers interview Chris Wasden, formerly CEO of Tympany Inc. and currently founder and CEO of SimplexityMD. Wasden searches for new medical technologies he can control, commercialize and bring to market. Wasden explains his process, which has already lead to the company's first portfolio venture, MC Nanotissues.
